Home / Course catalog / Hepatocellular Carcinoma (HCC Part ... (GEST18-107)

z-Archives → GEST 2018

Hepatocellular Carcinoma (HCC Part I) (GEST18-107)

Dr. Chuck Ray - University of Illinois College of Medicine
Dr. Kamran Ahrar - M.D. Anderson Cancer Center

Dr. Matthew Johnson - Indiana University School of Medicine
Dr. Erik Cressman - M.D. Anderson Cancer Center
Dr. Robert Lewandowski - Northwestern Memorial Hospital
Dr. Nadine Abi-Jaoudeh - University of California Irvine
Dr. Ari Isaacson - The University of North Carolina at Chapel Hill
Dr. Jafar Golzarian - University of Minnesota
Dr. Michael Soulen - Abramson Cancer Center / University of Pennsylvania

CME Credits: None MOC Credits: None GEST Year: 2018 Category: IO: Hepatocellular Carcinoma (HCC)

  • Dr. Ray - BCLC Staging System: Where Does it Fall Short Is HKLC Any Better?
  • Dr. Johnson - Pricey Microcatheters, Precious Radiopharma, Afford to Treat HCC?
  • Dr. Cressman - HCC Carcinogenesis and Immunology
  • Dr. Lewandowski - Evolving Role of SBRT and Proton for HCC
  • Dr. Abi-Jaoudeh - Immunotherapy for HCC: Current State of Development
  • Dr. Isaacson - Blood Flow Manipulation & Embolics Distribution
  • Dr. Golzarian - Global TACE Practice: Results of an International Survey
  • Dr. Soulen - cTACE Back in the Spotlight Rationale and Principles
  • Dr. Lewandowski - TARE: Fundamentals
  • Dr. Ahrar - Ablation: Pushing the Frontiers
Completion rules
  • All units must be completed